<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03018587</url>
  </required_header>
  <id_info>
    <org_study_id>C-16-TS12</org_study_id>
    <nct_id>NCT03018587</nct_id>
  </id_info>
  <brief_title>Feasibility Study of the TruSculpt Radiofrequency Device</brief_title>
  <official_title>Feasibility Study of the TruSculpt Radiofrequency Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cutera Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cutera Inc.</source>
  <oversight_info>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A single-center, prospective, open-label feasibility study of the truSculpt radiofrequency
      device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A single-center, prospective, open-label study to evaluate the safety and efficacy of the
      Cutera truSculpt radiofrequency device for optimal delivery of thermal energy to the skin.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">December 29, 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Investigator Assessment of Improvement</measure>
    <time_frame>At 12 weeks post-treatment</time_frame>
    <description>Degree of improvement in the treatment area at 12 weeks post-treatment compared with Baseline photo as assessed by the Investigator using Global Aesthetic Improvement Scale(GAIS): +4=Very Significant Improvement(&gt; or =75%), +3=Significant Improvement((51 - 75%), +2=Moderate Improvement((26 - 50%), +1=Mild Improvement((5 - 25%), or 0=No Change(5%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subject assessment of improvement at 12 weeks post-treatment</measure>
    <time_frame>At 12 weeks post-treatment</time_frame>
    <description>Subject will complete a questionnaire to asses improvement of treated area.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject satisfaction level at 12 weeks post-treatment</measure>
    <time_frame>At 12 weeks post-treatment</time_frame>
    <description>Subject will complete a questionnaire to asses treatment satisfaction.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject pain levels during treatment</measure>
    <time_frame>Within 5 to 10 minutes post-treatment</time_frame>
    <description>Using a numeric scale of 0 to 10, subject's will be asked to rate the average level of pain experienced during treatment.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Tissue Tightening</condition>
  <arm_group>
    <arm_group_label>TruSculpt</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject(s) will receive 1 radio frequency treatment in desired area.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TruSculpt</intervention_name>
    <description>Subject(s) will receive 1 Trusculpt (Radio Frequency) Device Treatment</description>
    <arm_group_label>TruSculpt</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or Female, 24 to 65 years of age (inclusive)

          2. Fitzpatrick Skin Type I - VI

          3. Has visible fat bulges or skin laxity in the treatment area

          4. Non-smoking for at least 6 months and willing to refrain from smoking for the duration
             of the study.

          5. Subject must agree to not undergo any other procedure(s) in the submental region
             during the study period.

          6. Subject must be able to read, understand and sign the Informed Consent Form.

          7. Subject must adhere to the follow-up schedule and study instructions.

          8. Willing to have digital photographs taken of the treatment area and agree to use of
             photographs for presentation, educational or marketing purposes.

          9. Post-menopausal or surgically sterilized, or using a medically acceptable form of
             birth control at least 3 months prior to enrollment and during the entire course of
             the study, and no plans to become pregnant.

        Exclusion Criteria:

          1. Participation in a clinical trial of another device or drug in the target area during
             the study period.

          2. Has a pacemaker, internal defibrillator, implantable cardioverter-defibrillator, nerve
             stimulator implant, cochlear implant or any other electronically, magnetically or
             mechanically activated implant.

          3. Has metal implant(s) within the body, such as surgical clips, plates and screws,
             intrauterine device (IUD), artificial heart valves or artificial joints.

          4. Significant concurrent illness, such as diabetes mellitus, cardiovascular disease,
             peripheral vascular disease or pertinent neurological disorders.

          5. Diagnosed or documented immune system disorders.

          6. History of any disease or condition that could impair wound healing.

          7. History of diseases stimulated by heat, such as recurrent herpes zoster in the
             treatment area, unless treatment is conducted following a prophylactic regimen.

          8. Infection, dermatitis, rash or other skin abnormality in the target area.

          9. Currently undergoing systemic chemotherapy or radiation treatment for cancer, or
             history of treatment in the target area within 3 months of study participation.

         10. Pregnant or currently breastfeeding.

         11. As per the Investigator's discretion, any physical or mental condition which might
             make it unsafe for the subject to participate in this study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen Ronan, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Principal Investigator</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cutera Research Center</name>
      <address>
        <city>Brisbane</city>
        <state>California</state>
        <zip>94005</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2017</study_first_submitted>
  <study_first_submitted_qc>January 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 12, 2017</study_first_posted>
  <last_update_submitted>February 1, 2018</last_update_submitted>
  <last_update_submitted_qc>February 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>None. No individual participant data will be shared with other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

